A retrospective cross-sectional survey study of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia
Latest Information Update: 25 Nov 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 25 Nov 2022 New trial record
- 22 Nov 2022 Results published in the Vaccine